Dubai Conference Was Success for Medical Services
February 15 2006 - 1:03PM
PR Newswire (US)
EDMONTON, Alberta, Feb. 15 /PRNewswire-FirstCall/ -- Medical
Services International Inc. (OTC:MSITF) is pleased to announce that
the Dubai Medical Conference was a huge success for the Company.
The Companies new distributor for the Middle East signed contracts
in three Middle East countries totaling 2.1 million kits over an 18
month period starting in September, 2006. These orders for the
VScan HIV test kit will generate gross revenues of $4.8 million US
over this period. There was also significant interest shown in the
Tuberculosis (TB) and Hepatitis C VScan test kits. In addition to
the contracts from the three countries, our distributor has been
contacted by representatives from another 6 countries. Samples have
been sent to the appropriate regulatory agencies in these countries
for testing to be completed. As soon as Medical Services receives
the pictures taken at the conference they will be added to the
website. About VScan The VScan rapid test kit is a single use,
disposable, accurate, cost effective, easy to use test for the
screening of HIV 1&2, Tuberculosis (TB), Hepatitis B&C
Dengue Fever, West Nile, Syphilis, Malaria and Prostate Cancer. The
kits cannot be sold in Canada. Medical Services International Inc.
trades in the United States on the NQB Pinksheets under the symbol
"MSITF". For further information, please contact Robert Talbot at
(780) 430 6363 or media contact Bill Whitehead at (416) 822 5883 or
http://www.medicalservicesintl.com/ or
http://www.minerva-biotech.com/ . NOTE: Certain statements in this
press release are "forward-looking statements" within the meaning
of the Private Securities Act of 1995. Such statements involve
known and unknown risks, uncertainties and other factors that may
cause results to differ materially. Such risks, uncertainties and
other factors include but are not limited to new economic
conditions, risk in product development, market acceptance of new
products and continuing product demand, level of competition and
other factors described in Company reports and other filings with
regulatory bodies. First Call Analyst: FCMN Contact: DATASOURCE:
Medical Services International Inc. CONTACT: Robert Talbot,
+1-780-430-6363 or Bill Whitehead, +1-416-822-5883, both of Medical
Services International Inc. Web site:
http://www.medicalservicesintl.com/ http://www.minerva-biotech.com/
Copyright